Adenocarcinoma in situ of the uterine cervix: Clinical practice guidelines from the Italian society of colposcopy and cervical pathology (SICPCV).
Ciavattini A, Giannella L, Delli Carpini G, Tsiroglou D, Sopracordevole F, Chiossi G, Di Giuseppe J; Italian Society of Colposcopy and Cervico-Vaginal Pathology (SICPCV).
Conservative Treatment for Cervical Adenocarcinoma In Situ: Long-Term Results.
Monti E, Somigliana E, Alberico D, Boero V, Iorio M, Di Loreto E, Dell'acqua A, Liverani CA.
J Low Genit Tract Dis. 2022 Oct 1;26(4):293-297. doi: 10.1097/LGT.0000000000000688. Epub 2022 Aug 3.
PMID:35917498
Cervical adenocarcinoma in situ.
Hopkins MP, Roberts JA, Schmidt RW.
Obstet Gynecol. 1988 Jun;71(6 Pt 1):842-4.
PMID:3285263
Cervical adenocarcinoma in situ: Human papillomavirus types and incidence trends in five states, 2008-2015.
Cleveland AA, Gargano JW, Park IU, Griffin MR, Niccolai LM, Powell M, Bennett NM, Saadeh K, Pemmaraju M, Higgins K, Ehlers S, Scahill M, Johnson Jones ML, Querec T, Markowitz LE, Unger ER; HPV-IMPACT Working Group.
Int J Cancer. 2020 Feb 1;146(3):810-818. doi: 10.1002/ijc.32340. Epub 2019 May 6.
PMID:30980692
Adenocarcinoma in situ or early-stage cervical cancer is a risk factor for preterm delivery after cervical conization: a multicenter observational study.
Kasuga Y, Ikenoue S, Nishio H, Yamagami W, Ochiai D, Tanabe K, Tashima Y, Hirao N, Miyakoshi K, Kasai K, Suda Y, Nemoto T, Shiraishi S, Yoshida H, Kurahashi T, Takamatsu K, Iwasaki S, Yamashita H, Akiba Y, Arase T, Hara S, Nakada S, Tanaka M, Aoki D.
Cervical Screening Results Leading to Detection of Adenocarcinoma in Situ of the Uterine Cervix.
Srisomboon S, Tantipalakorn C, Charoenkwan K, Srisomboon J.
Asian Pac J Cancer Prev. 2019 Feb 26;20(2):377-382. doi: 10.31557/APJCP.2019.20.2.377.
PMID:30803195
Performance of HPV DNA testing in the follow-up after treatment of high-grade cervical lesions, adenocarcinoma in situ (AIS) and microinvasive carcinoma.
Costa S, Venturoli S, Origoni M, Preti M, Mariani L, Cristoforoni P, Sandri MT.